Services
The end-to-end reimbursement and commercialization journey.
Three integrated practices — engaged individually or together — to move healthcare products from coding strategy to market and through investor scrutiny.
01
Coding & Reimbursement Support
Securing the right codes, coverage, and payment for pharmaceutical, device, and diagnostic products — including CPT/HCPCS strategy, CMS and commercial coverage dossiers, and rate analysis.
View Coding & Reimbursement Support details →02
Market Access
Payer strategy, pricing and contracting, value story and evidence planning, and pre-launch access roadmaps — ideally engaged 12 to 18 months before approval.
View Market Access details →03
Due Diligence
Reimbursement and commercial diligence for VC, PE, and investment banking teams evaluating healthcare targets — assessing coverage risk, pricing durability, and the realistic path to revenue.
View Due Diligence details →Ready to talk?
Let's discuss your reimbursement and access strategy.
Senior, partner-led engagements. Confidential by default.
